Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction
A.HammoudR.RittigN.et al (2024)
Literatur Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2a Current Step 4 version: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf (letzter Zugriff: 17
Novo Nordisk launched the product in the United States in January 2026, marking the first time an oral GLP-1 treatment had been cleared specifically for weight management
Western blot assay and real-time reverse transcription polymerase chain reaction further demonstrated that the expression of odonto/osteogenic markers (ALP, RUNX2/ RUNX2 , OSX/ OSX , OCN/ OCN , COL-I/ COL-I , DSPP/ DSP , and DMP-1/ DMP-1 ) in IGF-1 treated SCAPs were significantly upregulated in Let-7c -low group
Conversation matters more than finishing simultaneously